There were 138 press releases posted in the last 24 hours and 429,194 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image